111 related articles for article (PubMed ID: 16772709)
1. Enalapril reduces the expression of nuclear factor-kappaB and c-Jun N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats.
Costa JC; Costa RS; Silva CG; Coimbra TM
Am J Nephrol; 2006; 26(3):281-6. PubMed ID: 16772709
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
3. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.
Ghosh SS; Massey HD; Krieg R; Fazelbhoy ZA; Ghosh S; Sica DA; Fakhry I; Gehr TW
Am J Physiol Renal Physiol; 2009 May; 296(5):F1146-57. PubMed ID: 19225048
[TBL] [Abstract][Full Text] [Related]
4. Parthenolide reduces cisplatin-induced renal damage.
Francescato HD; Costa RS; Scavone C; Coimbra TM
Toxicology; 2007 Jan; 230(1):64-75. PubMed ID: 17156909
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC
Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis.
Francescato HD; Coimbra TM; Costa RS; Bianchi Mde L
Kidney Blood Press Res; 2004; 27(3):148-58. PubMed ID: 15118361
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
[TBL] [Abstract][Full Text] [Related]
9. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
10. Cecropia pachystachya extract attenuated the renal lesion in 5/6 nephrectomized rats by reducing inflammation and renal arginase activity.
Maquiaveli CC; da Silva ER; Rosa LC; Francescato HD; Lucon Júnior JF; Silva CG; Casarini DE; Ronchi FA; Coimbra TM
J Ethnopharmacol; 2014 Dec; 158 Pt A():49-57. PubMed ID: 25304199
[TBL] [Abstract][Full Text] [Related]
11. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.
Fujihara CK; Antunes GR; Mattar AL; Malheiros DM; Vieira JM; Zatz R
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F92-9. PubMed ID: 16896182
[TBL] [Abstract][Full Text] [Related]
13. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
[TBL] [Abstract][Full Text] [Related]
15. Lead activates nuclear transcription factor-kappaB, activator protein-1, and amino-terminal c-Jun kinase in pheochromocytoma cells.
Ramesh GT; Manna SK; Aggarwal BB; Jadhav AL
Toxicol Appl Pharmacol; 1999 Mar; 155(3):280-6. PubMed ID: 10079214
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
[TBL] [Abstract][Full Text] [Related]
18. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
20. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]